| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/14/2013 | US20130064911 Method and formulation for treating dry ear inflammation with cortisone |
| 03/14/2013 | US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 03/14/2013 | US20130064832 Notch inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof |
| 03/14/2013 | US20130064774 Methods and compositions for maintenance of a functional wound |
| 03/14/2013 | CA2847664A1 Antisense oligonucleotides for the treatment of leber congenital amaurosis |
| 03/14/2013 | CA2838289A1 Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| 03/13/2013 | EP2567955A2 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 03/13/2013 | EP2567689A1 Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| 03/13/2013 | CN102965250A Healthcare wine for senile deafness |
| 03/13/2013 | CN102961749A Application of fibrate drugs used as drugs for inhibiting myopia |
| 03/13/2013 | CN102961748A Method for reducing intraocular pressure by using gap junction blocker |
| 03/13/2013 | CN102961521A Drug for treating herpes simplex virus keratities |
| 03/13/2013 | CN102961513A Traditional Chinese medicine composition for treating nearsightedness excimer laser postoperative complication Haze and traditional Chinese medicine preparation |
| 03/13/2013 | CN102961432A Patch for treating deafness and tinnitus and preparation method thereof |
| 03/13/2013 | CN102961399A Sodium chloride eye drops and preparation method thereof |
| 03/13/2013 | CN102961390A Ophthalmic gel medicinal composition and preparation method thereof |
| 03/13/2013 | CN102961324A Gel for lysozyme eye and preparation method thereof |
| 03/13/2013 | CN102960805A Method for preparing healthcare drink for relieving eye fatigue |
| 03/13/2013 | CN102266445B Eye protection Chinese medicinal composition with health care and treatment effects |
| 03/13/2013 | CN102151312B Medicament for treating vitreous hematocele and preparation method thereof |
| 03/13/2013 | CN102070605B Imatinib mesylate polymorph and pharmaceutical composition |
| 03/13/2013 | CN101961486B 一种滴眼液及其制备方法 One kind of eye drops and its preparation method |
| 03/13/2013 | CN101903045B Pharmaceutical composition for treatment of cataract |
| 03/13/2013 | CN101605529B Stable formulations, and methods of their preparation and use |
| 03/13/2013 | CN101528239B Ophthalmic aqeous liquid preparation |
| 03/13/2013 | CN101346138B Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394771 Multimeric proteins and methods of making and using same |
| 03/12/2013 | US8394756 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2479927C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2453561C Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 03/07/2013 | WO2013033569A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | WO2013032938A1 Methods of sterilizing fetal support tissues |
| 03/07/2013 | WO2013032853A1 Activators of cxcr3 for the treatment of angiopathies of the eye |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031729A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 03/07/2013 | WO2013030367A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | WO2013030366A1 Novel soft rock inhibitors |
| 03/07/2013 | WO2013030365A1 Novel rock kinase inhibitors |
| 03/07/2013 | WO2012169849A3 Eye-drop composition for preventing or treating ocular diseases |
| 03/07/2013 | US20130059897 Rapid release irbesartan-containing pharmaceutical composition |
| 03/07/2013 | US20130059896 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/07/2013 | US20130059841 Therapeutic compositions and methods |
| 03/07/2013 | US20130059796 Cyclosporin compositions |
| 03/07/2013 | US20130059779 Stabilized Insulin-like Growth Factor Polypeptides |
| 03/07/2013 | US20130058954 Diagnostic and therapeutic methods for corneal ectasia following refractive surgery, keratoconus or pellucid degeneration |
| 03/07/2013 | US20130058951 Anti-s1p antibody treatment of patients with ocular disease |
| 03/07/2013 | US20130058927 Anti-vegf antibodies |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | CA2846695A1 Novel soft rock inhibitors |
| 03/07/2013 | CA2846694A1 Novel rock kinase inhibitors |
| 03/07/2013 | CA2846652A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | CA2844115A1 Methods of sterilizing fetal support tissues |
| 03/06/2013 | EP2565196A1 Prophylactic or therapeutic medication for inner ear disorders |
| 03/06/2013 | EP2565193A1 Compositions and methods for inhibition of the JAK pathway |
| 03/06/2013 | EP2564858A1 Composition for the treatment of aesthenopia |
| 03/06/2013 | EP2564853A1 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| 03/06/2013 | EP2563795A1 Inhibitors of protein tyrosine kinase activity |
| 03/06/2013 | EP2563794A1 Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
| 03/06/2013 | EP2563783A1 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators |
| 03/06/2013 | EP2563400A1 Modified binding proteins inhibiting the vegf-a receptor interaction |
| 03/06/2013 | EP2563395A2 Anti-s1p antibody treatment of patients with ocular disease |
| 03/06/2013 | EP2563359A1 Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| 03/06/2013 | EP2563352A1 Formulations of quinones for the treatment of ophthalmic diseases |
| 03/06/2013 | EP2563350A2 Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 03/06/2013 | EP2563119A1 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 03/06/2013 | CN102959458A Composition for contact lens care |
| 03/06/2013 | CN102958536A Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 03/06/2013 | CN102958526A Combination compositions of adenosine A1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure |
| 03/06/2013 | CN102958508A Ophthalmic devices containing chemokine antagonists |
| 03/06/2013 | CN102952777A Inducing method for directionally differentiating human embryonic stem cells to corneal endothelial cells |
| 03/06/2013 | CN102952729A Butterflybush flower healthcare wine for reducing sore red swollen eyes |
| 03/06/2013 | CN102952677A Black sesame deafness health-care wine |
| 03/06/2013 | CN102952138A Salts and polymorphic substances of pyrazolo pyrimidinone compound, pharmaceutical composition thereof, and preparation method and application thereof |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102949732A Medicine fusion specifically bound with human angiopoietin-2 |
| 03/06/2013 | CN102949586A Health care product used for benefiting qi and improving eyesight and preparation method thereof |
| 03/06/2013 | CN102949540A Traditional Chinese medicinal composite for treating cataract |
| 03/06/2013 | CN102949523A Medicinal composition used for relieving visual fatigue and preparation method of capsules thereof |
| 03/06/2013 | CN102949515A Borneol health-care wine used for controlling conjunctival congestion |
| 03/06/2013 | CN102949437A Traditional Chinese medicine for treating diabetic retinopathy and preparation method thereof |
| 03/06/2013 | CN102949404A Application of vanillic acid glucoside derivative in treatment of systemic autoimmune disease |
| 03/06/2013 | CN102949377A Acetazolamide sustained-release capsule and preparation method thereof |
| 03/06/2013 | CN102949349A Stable xanthophyll preparation |
| 03/06/2013 | CN102949345A Recombinant human epidermal growth factor cationic liposome and preparation method thereof |
| 03/06/2013 | CN102949336A Tobramycin ophthalmic in-situ gel eye-drops |
| 03/06/2013 | CN102949335A Preparation method of levofloxacin hydrochloride gel-type eye-drops |
| 03/06/2013 | CN102949334A Levofloxacin hydrochloride gel-type eye-drops |
| 03/06/2013 | CN102949331A Preparation method of tobramycin ophthalmic in-situ gel eye-drops |
| 03/06/2013 | CN102488674B Isoliquiritigenin eye drops and a preparation method thereof |